how to sell glp 1 Maximize Revenue With A Virtual GLP-1 Weight Loss Program Market Overview: GLP-1 Agonists and

Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al

Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as particularly promising pharmacologic agents for managing weight regain after bariatric surgery, leveraging mechanisms that complement the physiological effects of surgical intervention

Data showed that GLP-1 significantly increased PI3K, Akt, and mammalian target of rapamycin (mTOR) phosphorylation without inducing the expression of PI3K, Akt, or mTOR

Key Takeaways Nausea is one of the most common side effects of GLP-1 medications and is usually most noticeable when starting treatment or increasing your dose